Cargando…
Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
The prevalence of non-alcoholic fatty liver disease (NAFLD), now also known as metabolic dysfunction-associated fatty liver disease (MAFLD), is rapidly increasing worldwide due to the ongoing obesity epidemic. However, currently the NALFD diagnosis requires non-readily available imaging technologies...
Autores principales: | Miao, Zong, Garske, Kristina M., Pan, David Z., Koka, Amogha, Kaminska, Dorota, Männistö, Ville, Sinsheimer, Janet S., Pihlajamäki, Jussi, Pajukanta, Päivi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756520/ https://www.ncbi.nlm.nih.gov/pubmed/35047847 http://dx.doi.org/10.1016/j.xhgg.2021.100056 |
Ejemplares similares
-
Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Tauriainen, Milla-Maria, et al.
Publicado: (2018) -
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023) -
NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021) -
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021) -
Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)